Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brendan P Norman

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Advances in Clinical Chemistry|June 2, 2023
Alkaptonuria - Past, present and futureAndrew S Davison, Brendan P Norman
Journal of Inherited Metabolic Disease|July 9, 2019
Ochronotic pigmentation is caused by homogentisic acid and is the key event in alkaptonuria leading to the destructive consequences of the disease-A reviewLakshminarayan R Ranganath, Brendan P Norman, James A Gallagher
BMC Neurology|August 10, 2017
Early Onset Parkinson's Disease in a family of Moroccan origin caused by a p.A217D mutation in PINK1: a case reportBrendan P Norman, Steven J Lubbe, Manuela Tan, et al.
Metabolites|June 23, 2022
Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of AlkaptonuriaAndrew S Davison, Brendan P Norman, Hazel Sutherland, et al.
International Journal of Molecular Sciences|October 9, 2019
The Regulatory Role of MicroRNAs in Breast CancerHui-Yi Loh, Brendan P Norman, Kok-Song Lai, et al.
JIMD Reports|August 9, 2019
Evaluation of the serum metabolome of patients with alkaptonuria before and after two years of treatment with nitisinone using LC-QTOF-MSAndrew S Davison, Brendan P Norman, Gordon A Ross, et al.
Angewandte Chemie (International Ed. in English)|March 29, 2020
Pigmentation Chemistry and Radical-Based Collagen Degradation in Alkaptonuria and Osteoarthritic CartilageWing Ying Chow, Brendan P Norman, Norman B Roberts, et al.
JIMD Reports|July 5, 2023
Increased prevalence of Parkinson's disease in alkaptonuriaLakshminarayan Ranganath, Milad Khedr, Anna M Milan, et al.
International Journal of Molecular Sciences|April 13, 2023
Post-Transcriptional Regulatory Crosstalk between MicroRNAs and Canonical TGF-β/BMP Signalling Cascades on Osteoblast Lineage: A Comprehensive ReviewHui-Yi Loh, Brendan P Norman, Kok-Song Lai, et al.
JIMD Reports|January 14, 2022
Comparing nitisinone 2 mg and 10 mg in the treatment of alkaptonuria-An approach using statistical modellingLakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Advances in Clinical Chemistry|June 2, 2023
Alkaptonuria - Past, present and futureAndrew S Davison, Brendan P Norman
Journal of Inherited Metabolic Disease|July 9, 2019
Ochronotic pigmentation is caused by homogentisic acid and is the key event in alkaptonuria leading to the destructive consequences of the disease-A reviewLakshminarayan R Ranganath, Brendan P Norman, James A Gallagher
BMC Neurology|August 10, 2017
Early Onset Parkinson's Disease in a family of Moroccan origin caused by a p.A217D mutation in PINK1: a case reportBrendan P Norman, Steven J Lubbe, Manuela Tan, et al.
Metabolites|June 23, 2022
Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of AlkaptonuriaAndrew S Davison, Brendan P Norman, Hazel Sutherland, et al.
International Journal of Molecular Sciences|October 9, 2019
The Regulatory Role of MicroRNAs in Breast CancerHui-Yi Loh, Brendan P Norman, Kok-Song Lai, et al.
JIMD Reports|August 9, 2019
Evaluation of the serum metabolome of patients with alkaptonuria before and after two years of treatment with nitisinone using LC-QTOF-MSAndrew S Davison, Brendan P Norman, Gordon A Ross, et al.
Angewandte Chemie (International Ed. in English)|March 29, 2020
Pigmentation Chemistry and Radical-Based Collagen Degradation in Alkaptonuria and Osteoarthritic CartilageWing Ying Chow, Brendan P Norman, Norman B Roberts, et al.
JIMD Reports|July 5, 2023
Increased prevalence of Parkinson's disease in alkaptonuriaLakshminarayan Ranganath, Milad Khedr, Anna M Milan, et al.
International Journal of Molecular Sciences|April 13, 2023
Post-Transcriptional Regulatory Crosstalk between MicroRNAs and Canonical TGF-β/BMP Signalling Cascades on Osteoblast Lineage: A Comprehensive ReviewHui-Yi Loh, Brendan P Norman, Kok-Song Lai, et al.
JIMD Reports|January 14, 2022
Comparing nitisinone 2 mg and 10 mg in the treatment of alkaptonuria-An approach using statistical modellingLakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
Pageof 3